This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

13 Oct 2017

Maximising API performance with high purity excipients

Croda on hand at CPHI to increase API delivery and improve API stability.

At CPHI, Croda will be available to talk about their high purity pharmaceutical excipients that can be used to maximise the performance of APIs.

Croda will be located at stand 102B11, Hall 10.2, at the CPHI event, with sales, marketing and technical experts present to provide knowledge and expertise, showcasing their range of speciality ingredients using live demonstrations and offering product samples and literature.

Join Croda at CPHI to learn more about

  • · Improved API stability
  • · Reduced cellular irritation
  • · Increased API delivery
  • · Accelerated speed-to-market
  • · Reducing drug development times
  • · Simplifying formulations
  • At CPHI the focus will be on high purity pharmaceutical ingredients and the benefits they provide for multiple drug administration routes, including: parenteral, ophthalmic, oral and topical.

    Related News